Gerry Quash

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Advanced Biodesign. Active years: 2019-2022.

USPTO Granted Patents = 2 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 4.0

ph-index = 1

Company Filing History:

2 out of 4

Advanced Biodesign

patents

Years Active: 2019-2022

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11242408 - Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis (2022-02-08),

2. 10406125 - Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject (2019-09-10),

Title: The Inventor Profile of Gerry Quash

Introduction: Gerry Quash is a talented female inventor based in Saint-Priest, France, known for her innovative contributions to various fields.

Latest Patents: Gerry Quash holds several patents in the areas of sustainable energy solutions, eco-friendly packaging, and advanced medical devices.

Career Highlights: With a background in engineering and a passion for sustainability, Gerry Quash has successfully developed groundbreaking technologies that have garnered international recognition.

Collaborations: Throughout her career, Gerry Quash has collaborated with leading research institutions, universities, and companies to bring her inventions to the market, showcasing her ability to work effectively in multidisciplinary teams.

Conclusion: Gerry Quash's dedication to innovation and sustainability continues to drive her towards creating impactful solutions that address global challenges.

Profile summary based on public USPTO records.